veteran-centered care for advanced liver disease (vet-cald)

Conditions: Liver Diseases

Summary: advanced liver disease is a serious illness that disproportionately affects veterans, many of whom hope for curative liver transplantation. however, too few receive a transplant and most continue to suffer from increasing symptoms and hospitalizations. the proposed project uses a whole person, veteran-centered approach that identifies veterans with advanced liver disease using a population-based health management system and integrates curative and early supportive care using a telemedicine-based nurse care counselor to (1) discuss patient's understanding of illness severity and prognosis, (2) identify priorities and care preferences and (3) align curative and supportive care options to achieve patient priorities. study outcomes include changes in (1) rates of consideration for liver transplantation, and (2) completion of serious illness discussions. findings will inform adaptations to the intervention and facilitators for its dissemination.

project background and rationale: advanced liver disease (advld) is a serious illness. as many as half of advld patients die within 2 years of developing liver complications, and nearly all suffer increasing symptoms and hospitalizations. although many patients hope for curative liver transplantation, few receive it while experiencing an increasingly severe illness. in previous studies, many patients with advld reported unmet curative and supportive care needs. they also reported preferences to align care with their outcome goals earlier in the advld course than is now common. the vet-cald program is a whole health program in advld that focuses on what matters most to patients, shared goals, and goal-aligned treatments, and could improve both curative and supportive care. project objectives: the overall goal of the vet-cald project is to develop and test a novel sustainable whole health program in caring for patients with advld. using a hybrid type 1 effectiveness-implementation study design, the project will: (aim 1) conduct a formative assessment of vet-cald implementation for veterans with advld; (aim 2) evaluate the effectiveness of vet-cald in a randomized controlled study at 4 va centers; and (aim 3) conduct a summative assessment of implementation outcomes. project methods: in aim 1, the study team will conduct in-depth qualitative interviews with clinical stakeholders and patients to identify steps necessary to refine the vet-cald intervention, develop engagement processes for patients, and establish integrated workflows at the four targeted va sites. in aim 2 the study team will conduct a randomized clinical trial (n=450) with patients from 4 va medical centers assigned (1:1) to usual care vs. vet-cald intervention. the vet-cald intervention will consist of a centralized research care counselor who will work with individual patients by telehealth (5 visits over 6 months) to assess and cultivate their understanding of their illness and identify personal healthcare goals. the counselor will be part of a centralized care team (hepatologist and supportive care physician) and will work with each patient's usual providers to help tailor treatment plans and education to better align with each patient's understanding of their disease prognosis and their healthcare goals and priorities. in aim 3, summative assessment will provide context for the effectiveness results and inform necessary adaptations to and dissemination of vet-cald.

Eligibility criteria:
inclusion criteria: * patients will be between 18 and 80 years of age * patients must be veterans * patients must have been in care at one of the recruiting sites for 1 year with two or more encounters in primary care * patients must have advld, defined based on two ambulatory or one inpatient encounter icd-10 codes for new onset cirrhosis complications or meld-na \>15 in the previous 12 months exclusion criteria: * non-veteran patients * patients who do not speak english, do not have access to a telephone or computers, or who are unable to complete a valid informed consent form after three attempts * patients who have already made significant progress toward our endpoints: a) with prior history of liver transplantation, or b) on the liver transplant waiting list, or c) had formal evaluation for liver transplantation in the past 3 years * patients with very limited life expectancy (advanced cancer, acute-on-chronic liver failure, and hospice patients) * patients hospitalized, or in long term facilities or nursing homes at the time they meet inclusion criteria * patients with chart diagnosis of uncontrolled mental health or schizophrenia

Keywords: patient-centered care randomized controlled trial delivery of healthcare, integrated